FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214608035> ?p ?o ?g. }

• W4214608035 endingPage "539" @default.
• W4214608035 startingPage "529" @default.
• W4214608035 abstract "We aimed to study whether antipsychotic use during pregnancy is associated with gestational diabetes.This was a Swedish national register-based cohort study on the Medical Birth Register and the Prescribed Drug Register including all 1,307,487 singleton births between July 2006 and December 2017. Antipsychotics were divided into first-generation antipsychotics (n = 728), high-risk metabolic second-generation antipsychotics including olanzapine, clozapine and quetiapine (n = 1710), and other second-generation antipsychotics (n = 541). The risks for gestational diabetes, foetal growth disturbances, pre-eclampsia, caesarean section and preterm labour were assessed. Women treated during pregnancy were compared to women not treated during pregnancy and to women who used antipsychotics before/after but not during pregnancy.The crude risk ratio for gestational diabetes for women treated with high-risk metabolic second-generation antipsychotics during pregnancy was 2.2 (95% confidence interval [CI] 1.6-2.9) compared to untreated pregnant women (n = 1,296,539) and 1.8 (95% CI 1.4-2.5) compared to women treated before/after pregnancy (n = 34,492). After adjustment for maternal factors including body mass index, the risk ratios were 1.8 (95% CI 1.3-2.4) and 1.6 (95% CI 1.2-2.1). Exposed infants had an increased risk of being large for gestational age: adjusted risk ratios 1.6 (95% CI 1.3-1.9) and 1.3 (95% CI 1.1-1.6) compared to no maternal antipsychotic use during pregnancy and maternal use before/after the pregnancy. Other antipsychotics were not associated with metabolic risks.Olanzapine, clozapine and quetiapine used during pregnancy were associated with increased risks for gestational diabetes and the infant being large for gestational age. Enhanced metabolic monitoring should be considered for pregnant women using these drugs.The use of second-generation antipsychotics amongst pregnant women is increasing. The side effects of these drugs, for example weight gain and increased blood sugar, are well described for the general population. In particular, olanzapine, quetiapine and clozapine are known to cause these effects. Studies on their effects on blood sugar control in pregnant women have however been conflicting. Pregnancy itself also imposes a risk for increased blood sugar levels and gestational diabetes. The purpose of this study was to evaluate the risk of gestational diabetes connected to the use of antipsychotics during pregnancy. The study was nationwide and register based including 1.3 million births in Sweden between July 2006 and December 2017. The rates of gestational diabetes and the infants being small for gestational age or large for gestational age amongst women treated with antipsychotics were compared to the rates in pregnant women who did not receive antipsychotics and to rates in a control group of women treated with antipsychotics before/after but not during pregnancy. Antipsychotics were divided into three groups: (i) first-generation antipsychotics, (ii) high-risk second-generation antipsychotics including olanzapine, quetiapine and clozapine, and (iii) other second-generation antipsychotics. Women treated with high-risk second-generation antipsychotics were found to have an increased risk of gestational diabetes and giving birth to an infant being large for gestational age, both when compared with untreated pregnant women and with the control group. Other antipsychotics were not connected to increased risks of these outcomes. Hence, pregnant women treated with olanzapine, quetiapine or clozapine should be monitored regarding blood sugar levels." @default.
• W4214608035 created "2022-03-02" @default.
• W4214608035 creator A5030333540 @default.
• W4214608035 creator A5042904422 @default.
• W4214608035 creator A5048350841 @default.
• W4214608035 creator A5064316683 @default.
• W4214608035 creator A5076599212 @default.
• W4214608035 date "2022-02-26" @default.
• W4214608035 modified "2023-10-14" @default.
• W4214608035 title "Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden" @default.
• W4214608035 cites W1592674309 @default.
• W4214608035 cites W1960792000 @default.
• W4214608035 cites W1966103551 @default.
• W4214608035 cites W1975483564 @default.
• W4214608035 cites W1995464752 @default.
• W4214608035 cites W2031964928 @default.
• W4214608035 cites W2042123542 @default.
• W4214608035 cites W2058913093 @default.
• W4214608035 cites W2061525750 @default.
• W4214608035 cites W2067911406 @default.
• W4214608035 cites W2076415603 @default.
• W4214608035 cites W2089955483 @default.
• W4214608035 cites W2103154101 @default.
• W4214608035 cites W2106569717 @default.
• W4214608035 cites W2109334478 @default.
• W4214608035 cites W2114964939 @default.
• W4214608035 cites W2123533219 @default.
• W4214608035 cites W2135245979 @default.
• W4214608035 cites W2136191424 @default.
• W4214608035 cites W2138969725 @default.
• W4214608035 cites W2139379359 @default.
• W4214608035 cites W2139548552 @default.
• W4214608035 cites W2141081839 @default.
• W4214608035 cites W2148893811 @default.
• W4214608035 cites W2150553839 @default.
• W4214608035 cites W2153763854 @default.
• W4214608035 cites W2155353134 @default.
• W4214608035 cites W2164142166 @default.
• W4214608035 cites W2168021466 @default.
• W4214608035 cites W2172102086 @default.
• W4214608035 cites W2255104527 @default.
• W4214608035 cites W2333051721 @default.
• W4214608035 cites W2415987365 @default.
• W4214608035 cites W2440624394 @default.
• W4214608035 cites W2481322231 @default.
• W4214608035 cites W2556155422 @default.
• W4214608035 cites W2597844775 @default.
• W4214608035 cites W2604382917 @default.
• W4214608035 cites W2623772785 @default.
• W4214608035 cites W2625411514 @default.
• W4214608035 cites W2626145528 @default.
• W4214608035 cites W2740421642 @default.
• W4214608035 cites W2781501523 @default.
• W4214608035 cites W2801381076 @default.
• W4214608035 cites W2803169348 @default.
• W4214608035 cites W2885315534 @default.
• W4214608035 cites W2909184862 @default.
• W4214608035 cites W2940949373 @default.
• W4214608035 cites W2945791995 @default.
• W4214608035 cites W2982167270 @default.
• W4214608035 cites W2984633396 @default.
• W4214608035 cites W3195601230 @default.
• W4214608035 cites W4211069648 @default.
• W4214608035 doi "https://doi.org/10.1007/s40263-022-00908-2" @default.
• W4214608035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35220525" @default.
• W4214608035 hasPublicationYear "2022" @default.
• W4214608035 type Work @default.
• W4214608035 citedByCount "5" @default.
• W4214608035 countsByYear W42146080352022 @default.
• W4214608035 countsByYear W42146080352023 @default.
• W4214608035 crossrefType "journal-article" @default.
• W4214608035 hasAuthorship W4214608035A5030333540 @default.
• W4214608035 hasAuthorship W4214608035A5042904422 @default.
• W4214608035 hasAuthorship W4214608035A5048350841 @default.
• W4214608035 hasAuthorship W4214608035A5064316683 @default.
• W4214608035 hasAuthorship W4214608035A5076599212 @default.
• W4214608035 hasBestOaLocation W42146080351 @default.
• W4214608035 hasConcept C118552586 @default.
• W4214608035 hasConcept C126322002 @default.
• W4214608035 hasConcept C131872663 @default.
• W4214608035 hasConcept C201903717 @default.
• W4214608035 hasConcept C2776412080 @default.
• W4214608035 hasConcept C2776619155 @default.
• W4214608035 hasConcept C2779234561 @default.
• W4214608035 hasConcept C2779434492 @default.
• W4214608035 hasConcept C2780634440 @default.
• W4214608035 hasConcept C29456083 @default.
• W4214608035 hasConcept C46973012 @default.
• W4214608035 hasConcept C54355233 @default.
• W4214608035 hasConcept C71924100 @default.
• W4214608035 hasConcept C86803240 @default.
• W4214608035 hasConceptScore W4214608035C118552586 @default.
• W4214608035 hasConceptScore W4214608035C126322002 @default.
• W4214608035 hasConceptScore W4214608035C131872663 @default.
• W4214608035 hasConceptScore W4214608035C201903717 @default.
• W4214608035 hasConceptScore W4214608035C2776412080 @default.
• W4214608035 hasConceptScore W4214608035C2776619155 @default.
• W4214608035 hasConceptScore W4214608035C2779234561 @default.

• next